- Home
- TYL vs SNN Comparison
TYL vs SNN Comparison
Compare TYL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TYL | SNN |
|---|---|---|
| Founded | 1966 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 14.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | TYL | SNN |
|---|---|---|
| Price | $351.76 | $32.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $478.91 | $36.25 |
| AVG Volume (30 Days) | 535.8K | ★ 786.8K |
| Earning Date | 04-22-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | ★ 19.01 | N/A |
| EPS | ★ 7.20 | N/A |
| Revenue | ★ $493,101,000.00 | N/A |
| Revenue This Year | $9.63 | $7.19 |
| Revenue Next Year | $9.66 | $5.36 |
| P/E Ratio | ★ $48.84 | $64.97 |
| Revenue Growth | ★ 18.35 | N/A |
| 52 Week Low | $283.72 | $23.91 |
| 52 Week High | $621.34 | $38.79 |
Technical Indicators
Market Signals| Indicator | TYL | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 34.16 |
| Support Level | $341.98 | $29.27 |
| Resistance Level | $373.88 | $33.89 |
| Average True Range (ATR) | 10.66 | 0.63 |
| MACD | 1.46 | -0.30 |
| Stochastic Oscillator | 28.04 | 6.34 |
Price Performance
Historical ComparisonAbout TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.